Fairfax's US$5.6 Billion IDBI Bank Stake Shows Why India Draws Global Capital

Indian rules generally stop any single long-term investor from holding more than 26% of a private bank, which makes it worth asking why a Toronto insurer is walking away with control of one. Fairfax Financial, Prem Watsa's company, has a deal worth roughly US$5.6 billion for a majority stake in IDBI Bank. The Government of India and Life Insurance Corporation of India are selling a combined stake of about 60.7%, and the government signalled flexibility on ownership limits to bring in global money.

The deal tells you what international investors are actually paying for in India. GDP growth is part of it, but the main prize is control of a licensed lender inside a credit system that is expanding quickly, and that control is very hard to get. Anyone judging emerging-market financials should treat regulatory access as part of the asset, alongside growth, because the access is what makes the growth something you can own.

Credit growth tells you more than GDP

The IMF expects India to grow at roughly 7% a year in 2026 and 2027. Bank credit has moved faster than that.

A bank's earnings follow its loan book. When households and businesses borrow faster than the economy grows, a lender with distribution can grow profits faster than GDP for years. IDBI brings more than 2,000 branches and a full commercial banking licence, the result of its long conversion from a development finance institution. For Fairfax, it's a step up from the airports and industrial holdings it has owned through Fairfax India Holdings, listed on the Toronto Stock Exchange, into the centre of the economy: everyday consumer and business lending.

For an analyst, the signal to watch is credit growth relative to nominal output, and who holds the branches that capture it.

Passing the regulator is worth money

The Reserve Bank of India runs some of the strictest "fit and proper" tests for bank owners anywhere. It cleared Fairfax and Kotak as bidders before financial bids, reported by Dec 2025. The winning bidder still has to complete the RBI's fit-and-proper assessment, which remains the biggest obstacle to foreign control of a major Indian bank and is still pending after the Oct 14, 2026 cabinet approval. Very few foreign groups will ever get through that review with a controlling stake.

That scarcity has a price. When control is rare, the buyer that gets approved holds something rivals can't easily copy. Some of what Fairfax is paying for is the approval itself, built up through years of governance records the regulator could inspect. Fairfax is also one of several Canadian institutions, along with CPPIB and Ontario Teachers', that have stayed heavily invested in India through periods of diplomatic strain between the two countries. They are committing for the long term.

Your return depends on the rupee and the old loan book

Two things decide what a North American investor actually earns.

The first is currency. Over long periods the rupee has tended to lose value against the US and Canadian dollars. As an illustration only: a holding that compounds at 12% a year in rupees, while the rupee slips 3% a year against the Canadian dollar, returns roughly 9% a year in Canadian terms. The growth is real, and part of it disappears on conversion.

The second is history. State-run Indian banks have struggled in the past with non-performing assets. IDBI's balance sheet has cleaned up a great deal, but a new owner inherits every old lending decision. The sale has also dragged on for years, because selling state assets is politically sensitive in India, and those delays cost money too.

So when you look at any emerging-market lender, ask three questions. How fast is credit growing compared with the economy? Who has regulatory clearance to own it? What will currency and legacy loans take off the top? Fairfax's bet on IDBI is a clear answer to all three, and it's a useful template for judging the next deal that claims India as its reason.